Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.52 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.52 |
| ▸ | CA12 known ✓ | O43570 | 1/20 | 0.39 |
| ▸ | CA4 known ✓ | P22748 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | DUSP5 | Q16690 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.43 |
| ▸ | CASP6 | P55212 | 1/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Silver SCHEMBL9550115 | 0.94 | CA2 (0.52) | LMNATDP1CA1CA2DUSP5 | |
| SCHEMBL2289282 | 0.94 | CA2 (0.52) | LMNATDP1CA1CA2DUSP5 | |
| SCHEMBL9550124 | 0.94 | CA2 (0.52) | LMNATDP1CA1CA2DUSP5 | |
| Potassium Ion SCHEMBL2785770 | 0.94 | CA2 (0.52) | LMNATDP1CA1CA2DUSP5 | |
| SCHEMBL29458759 | 0.93 | LMNA (0.52) | LMNATDP1CA1CA2DUSP5 | |
| SCHEMBL3942912 | 0.93 | LMNA (0.52) | LMNATDP1CA1CA2DUSP5 | |
| SCHEMBL22204350 | 0.89 | ALDH1A1 (0.55) | LMNATDP1CA1CA2DUSP5 | |
| Potassium Ion SCHEMBL30400899 | 0.87 | LMNA (0.52) | LMNATDP1CA1CA2KMT2A | |
| Potassium Ion SCHEMBL135380 | 0.87 | LMNA (0.52) | LMNATDP1CA1CA2KMT2A | |
| SCHEMBL15509797 | 0.87 | LMNA (0.50) | LMNATDP1CA1CA2DUSP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 491 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250049674-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST A MEROCYANINE AND A HYDROTROPE | L'OREAL (FR) | 2025-02-13 | — | — | US | claimed |
| US-20240423888-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST ONE MEROCYANINE AND AT LEAST ASCORBIC ACID AND/OR A DERIVATIVE THEREOF | L'OREAL (FR) | 2024-12-26 | — | — | US | claimed |
| US-12146184-B2 | Blood glucose measurement reagent, sensor chip, and blood glucose meter set | TERUMO KABUSHIKI KAISHA (JP) | 2024-11-19 | — | — | US | claimed |
| CN-118871078-A | Cosmetic or dermatological composition comprising at least a merocyanine and a hydrotrope | 欧莱雅 | 2024-10-29 | — | — | CN | claimed |
| EP-4447895-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST ONE MEROCYANINE AND AT LEAST ASCORBIC ACID AND/OR A DERIVATIVE THEREOF | L'OREAL (FR) | 2024-10-23 | — | — | EP | claimed |
| CN-118804735-A | Cosmetic and/or dermatological composition comprising at least one merocyanine and at least ascorbic acid and/or derivatives thereof | 莱雅公司 | 2024-10-18 | — | — | CN | claimed |
| CN-114835612-B | Synthetic method for preparing m-aminophenol | 青岛科技大学 | 2024-09-24 | — | — | CN | claimed |
| CN-111788472-B | Method, reagent and chip for determining concentration of analyte in biological sample | 泰尔茂株式会社 | 2023-12-15 | — | — | CN | claimed |
| US-11719701-B2 | Blood glucose level measuring chip and blood glucose level measuring device set | TERUMO KABUSHIKI KAISHA (JP) | 2023-08-08 | — | — | US | claimed |
| WO-2023110772-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST A MEROCYANINE AND A HYDROTROPE | L'OREAL (FR) | 2023-06-22 | — | — | WO | claimed |
| US-20030195134-A1 | Detergent granule comprising a nonionic surfactant and a hydrotrope | THE PROCTER & GAMBLE COMPANY | 2003-10-16 | — | — | US | claimed |
| EP-1352951-A1 | Detergent granule comprising a nonionic surfactant and a hydrotrope | The Procter & Gamble Company (US) | 2003-10-15 | — | — | EP | claimed |
| US-5958368-A | HYDROTHERMAL REACTION OF ALKYLTRIMETHYLAMMONIUM HALIDE AND WATER SOLUBLE ORGANIC SALTS; CALCINING RESULTING PRECIPITATE; RANDOMLY INTERCONNECTED CHANNELS OF UNIFORM DIAMETER ALLOW DIFFUSION OF REACTANTS; IMPROVED HYDROTHERMAL STABILITY | YUKONG LIMITED (KR) | 1999-09-28 | — | — | US | claimed |
| US-5942208-A | STABILIZING THE HYDROTHERMAL REACTION OF ZEOLITE MCM-41 BY MIXING ALKYLTRIMETHYLAMMONIUM SURFACTANT; SUBJECTING TO HYDROTHERMAL REACTION; MIXING ORGANIC OR INORGANIC WATER-SOLUBLE SALTS; HYDROTHERMAL REACTION; CALCINING | YU KONG LIMITED (KR) | 1999-08-24 | — | — | US | claimed |
| EP-0661965-B1 | HAIR CONDITIONING STYLE CONTROL SHAMPOO | COLGATE PALMOLIVE CO (US) | 1999-06-30 | — | — | EP | claimed |
| EP-0400657-B1 | Process for developing of ps plates requiring no dampening water | FUJI PHOTO FILM CO LTD (JP) | 1996-03-27 | — | — | EP | claimed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | claimed |
| EP-0661965-A1 | HAIR CONDITIONING STYLE CONTROL SHAMPOO | Colgate-Palmolive Company (US) | 1995-07-12 | — | — | EP | claimed |
| WO-1994006410-A1 | HAIR CONDITIONING STYLE CONTROL SHAMPOO | COLGATE-PALMOLIVE COMPANY (US) | 1994-03-31 | — | — | WO | claimed |
| US-5290665-A | Process for developing PS plate requiring no dampening water wherein the developer comprises, water, a solubilizer and an ethylene glycol mono(alkyl C6 -C8) ether derivative | FUJI PHOTO FILM CO., LTD. (JP) | 1994-03-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240423888-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST ONE MEROCYANINE AND AT LEAST ASCORBIC ACID AND/OR A DERIVATIVE THEREOF | KRT18, PROC, DSC1 | CA1 1327/4885CA2 797/4885CA12 547/4885 |
| US-20250049674-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST A MEROCYANINE AND A HYDROTROPE | NAPRT, NAMPT, NNMT | CA1 440/4885CA2 393/4885CA12 961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.